Mar 23, 2023, 09:24 AM by

Samsung Biologics (KRX: 207940.KS), a leading contract development and manufacturing organization (CDMO), announced today that the company will commence the construction of a fifth plant as part of its strategic expansion in response to increased market demand.

Mar 22, 2023, 09:52 AM by User Not Found

Bio-IT World | When it comes to breast cancer, the most commonly occurring estrogen receptor-positive (ER+) variety is a poor candidate for treatment with conventional immunotherapies designed to help the patient’s own immune system fight back. Unlike triple-negative breast cancer, ER+ tumors don’t have many infiltrating T cells so potentiating their function alone doesn’t make much of a difference.

Mar 22, 2023, 09:18 AM by

Former global head of new products at Sanofi Pasteur to lead Vaxess’s business and product development strategy

Mar 22, 2023, 09:18 AM by

Mar 22, 2023, 09:18 AM by

Mar 22, 2023, 09:17 AM by

Mar 22, 2023, 09:16 AM by

There are both large and small ADC molecules. A variety of biological analysis methods and platforms are needed to analyze the diversity of ADCs.

Mar 22, 2023, 09:15 AM by

92% of participants want to know about Alzheimer’s early according to new Linus Health report

Mar 22, 2023, 09:15 AM by

Driving more complete decisions for biopharmaceutical companies with modern digital pathology

Mar 21, 2023, 09:36 AM by

Flagship software platform further unifies pathology workflows and data across the R&D value chain

Mar 21, 2023, 09:36 AM by

VERICHEM LABORATORIES now offers multi-level calibration verification materials for amylase and lipase activity as part of its liquid stable, ready-to-use Enzyme ER™ Verifier Kit.

Mar 21, 2023, 09:36 AM by

Mar 21, 2023, 09:34 AM by

In the wake of the COVID-19 pandemic, BOC Sciences, the world's reputed chemical supplier, declares that it will increase production to offer pharmaceutical impurity standards in bulk to satisfy unmet demands.

Mar 21, 2023, 09:34 AM by

International strategic health and life science specialists Inizio have increased their organizational-wide focus on diversity, equity, and inclusion with the appointment of Stefanie Christmas as their new Global Head of Diversity, Equity & Inclusion (DE&I).

Mar 21, 2023, 01:00 AM by User Not Found

Bio-IT World | A research team from the Nagoya University Graduate School of Medicine, Japan, discovered three gut bacteria types that may lead to predicting and treating dementia with Lewy bodies.

Mar 16, 2023, 09:42 AM by

It will provide strategies to de-risk each stage of the R&D pipeline, with particular focus on regulatory drivers, investigatory objectives, and practical concerns that are relevant to toxicologists.

Mar 16, 2023, 09:42 AM by

Arranta Bio, a Recipharm company and leading contract development and manufacturing organization (CDMO) supporting advanced therapy pioneers, has announced that it has doubled capacity at its Watertown, MA facility for process development services supporting RNA therapeutics.

Mar 16, 2023, 01:00 AM by User Not Found

Bio-IT World | Insufficient taxonomic information in public sequence records is a longstanding problem that was again brought to light in a recent study of simulated microbial communities. Researchers in Spain, using standard techniques to explore virtual microbiome communities, found that results obtained from DNA analyses bear little resemblance to the real-world bacterial populations being imitated and many of the detected species are not actually present.

Mar 15, 2023, 14:25 PM by

Mural Health, a clinical trials technology company that improves the patient and caregiver experience in order to improve enrollment rates, participant retention, and increase protocol compliance and ProofPilot, the industry's first digital protocol automation platform for clinical trial, today announced a strategic partnership to further advance clinical trial operations for life science customers. Through this partnership, Mural Health’s Mural Link™ platform and ProofPilot’s platform work together to progress clinical operations and materially improve the efficiency, and outcomes, of global clinical trials.

Mar 15, 2023, 14:25 PM by

The COVID-19 pandemic has had a major impact on the implant industry, both positively and negatively. Here are some of the main effects: